Top Markets
Coin of the day
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc.

MLND
Rang in aandelen #40617
Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to... Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to developing innovative therapies for rare hormonal disorders, primarily within the United States. The company's key therapeutic candidates include livoletide, an investigational drug aimed at Prader-Willi syndrome; nevanimibe, an experimental compound designed for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist intended to alleviate vasomotor symptoms (such as hot flashes) in women experiencing menopause. This enterprise maintains its primary operational base in Ann Arbor, Michigan.
Aandeelprijs
$1.06
Laatst gesynchroniseerd: 2021-06-25
Marktkapitalisatie
$110.93K
Verandering (1 dag)
-5.36%
Verandering (1 jaar)
0.00%
Land
US
Handel Millendo Therapeutics, Inc. (MLND)

Categorie

Dividendrendementgeschiedenis voor Millendo Therapeutics, Inc. (MLND)
Het dividendrendement (TTM) van Millendo Therapeutics, Inc. (aandelsymbool: MLND) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Millendo Therapeutics, Inc. (MLND) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten